Table 3 Multivariable regression analysis was performed to adjust for confounders, including tumor size and stage, between PLELC and LSQ
Covariate | LSQ (n = 31) | PLELC (n = 31) | p value |
|---|---|---|---|
Radiologic response, n (%) | 0.11 | ||
Unknown | 0 (0) | 1 (3%) | |
CR | 0 (0) | 2 (6%) | |
PD | 0 (0) | 2 (6%) | |
PR | 17 (55%) | 19 (61%) | |
SD | 14 (45%) | 7 (23%) | |
Pathological valuation, n (%) | < 0.01 | ||
nNon-MPR | 12 (39%) | 21 (68%) | |
MPR | 7 (23%) | 8 (26%) | |
PCR | 12 (39%) | 2 (6%) | |
DFS (months) | 0.54 | ||
Mean (min, max) | 15.1 (1,29) | 17.4 (5,40) |